What to do about CAM?

What To Do About Vitamins

book must have been produced under great pressure, errors in the text are conspicuously few (e.g., the listing of the Toxoplasmideae under the Fungi). Everything considered, this is an excellent book for anyone wishing to take stock of the present status of penicillin therapy. "If you are a typical Amencan," says Dr. Williams, author of this little book for the lay reader, "you are interested i...

What to Do about Interlanguage

A potentially fruitful area for applied linguistic research is the nature of the linguistic systems used by second language learners as they learn--or even after they appear to have stopped learning. It has been suggested at various times that the findings of this sort of research would be useful not only to language teachers and textbook writers, but also to our understanding of language conta...

What to do about data?

The cost of sequencing whole mammalian genomes continues to plummet. New sequencing technologies are in development in many locations around the world, promising miraculously low prices and unbelievably short analysis times. When discussing the ‘$1,000 genome’, the question is no longer whether it will be achievable, but when. No matter how cheap sequencing the human genome can be, there is alw...

What your patient needs to know about CAM.

What to do about ischemic mitral regurgitation?

M itral regurgitation (MR) can be classified as either degenerative or functional. Degenerative MR is due to disease, deformity, or damage of the mitral valve or its supporting apparatus. Functional MR is caused by improper coaptation of normal leaflets and apparatus and is due primarily to abnormalities of the left ventricle. Ischemic MR is a subset of functional MR (papillary muscle rupture, ...